Tanaka T, Tamura R, Takei J, Morimoto Y, et al. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab
and temozolomide for newly diagnosed glioblastoma. J Neurooncol 2024 Jan 31. doi: 10.1007/s11060-023-04544.
PMID: 38291182
|